This is the case of a patient who presented prostate adenocarcinoma, but who also developed a secondary hepatotoxicity caused by flutamide.
En este artículo se presentará el caso de un paciente con adenocarcinoma de próstata, quien desarrolla hepatotoxicidad secundaria a flutamida.